1 min de lecture
[Press Release] XAV19 : validation of the first dose of anti-Covid treatment of XENOTHERA
-
-
Auteurcontact@xenothera.com
-
Publié12 novembre 2020
Articles récents
[Press Alert] Safety and efficacy results of LIS1
June 2022. # Download our press information (english version) # Télécharger notre...
More[Press Information] XENOTHERA presents LIS1 results at the American Transplant Congress (ATC) in Boston
May 2022. # Download our press information (english version) # Télécharger notre...
More[ Press Information ] APPOINTMENTS
April 2022. # Download our press information (english version) # Télécharger notre...
More